drugset / Trial / NCT00357188
Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study is to assess the exposure of Atazanavir 400 mg with Ritonavir 100 mg and with Efavirenz 600 mg compared to Atazanavir 300 mg with 100 mg without Efavirenz in Healthy Subjects
Timeline
- Start
- 2006-07
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atazanavir | Other / unclassified | 300 mg | Oral |
| Comparator | Atazanavir | Other / unclassified | 400 mg | Oral |
| Comparator | Efavirenz | Other / unclassified | 600 mg | Oral |
| Comparator | Ritonavir | Other / unclassified | 100 mg | Oral |